Covid19 Clinical Trial
Official title:
Correlation of Fear of COVID-19 Infection and Dental Treatment Anxiety Among Netizens: A Cross-sectional Study.
NCT number | NCT04497818 |
Other study ID # | QassimU2 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 16, 2020 |
Est. completion date | July 25, 2020 |
Verified date | August 2020 |
Source | Qassim University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Purpose:
COVID-19 Pandemic has created fears, anxiety and worries among general population. COVID-19
airborne transmission is possible under circumstances in which procedures generate aerosols.
Various dental treatment procedures can generate aerosols. This Cross Sectional Observational
study was conducted with the following objectives: 1. Assessment of Fear of COVID-19 among
netizens in Al Qassim province using FEAR OF COVID-19, a 5 item Likert Scale. 2. Assessment
of Dental Anxiety among netizens in Al Qassim provincen using (MDA) Modified Dental Anxiety 5
item Likert Scale.
Methods: Sample size was (n=385) estimated based on the population size in Al Qassim province
(Confidence Interval 95%, Design effect 1 & hypothesized % frequency of outcome factor of
50%). Assessment of Fear of COVID-19 was estimated using FEAR OF COVID-19, a 5 item Likert
Scale. Assessment of Dental Anxiety was estimated using Modified Dental Anxiety 5 item Likert
Scale. An online Survey form (Arabic & English) was developed using Google form application.
The Google form link was shared to the netizens of Al Qassim province, across Social media
platforms. Statistical analysis is done using SPSS 22.00 software program.
Status | Completed |
Enrollment | 385 |
Est. completion date | July 25, 2020 |
Est. primary completion date | July 16, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - Male and Female Human volunteer internet users who belong &/or reside in Al Qassim province region of Saudi Arabia. - Volunteers should be major by age (18 years and above). - People who took Dental treatment earlier in their lifetime. - People who may take the Dental treatment in near few days or weeks or months or in a year. Exclusion Criteria: - Minor age group (<18 years) subjects are excluded from the study. - Internet users who have preexisting phobia and/or anxiety mental conditions are excluded from the study. - Internet users who are currently under treatment for their preexisting phobia and/or anxiety mental conditions are excluded from the study. |
Country | Name | City | State |
---|---|---|---|
Saudi Arabia | Dr Bugude Shiva Shankar | Ar Rass | Al Qassim |
Lead Sponsor | Collaborator |
---|---|
Qassim University |
Saudi Arabia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fear of COVID-19 infection | Assessed Fear of COVID-19 among netizens in Al Qassim province using FEAR OF COVID-19, a 5 item Likert Scale. Descriptive statistics is used to present the data. | 5th August 2020 | |
Primary | Dental Anxiety | Assessed Dental Anxiety among netizens in Al Qassim province using (MDA) Modified Dental Anxiety 5 item Likert Scale. Descriptive statistics is used to present the data. | 5th August 2020 | |
Primary | Correlation of Fear of COVID-19 infection & Dental Anxiety | The survey data is statistically analyzed to check for the correlation of the Fear of COVID-19 with Dental Anxiety among Netizens in Qassim region. The data obtained from the survey is subjected to appropriate analytical statistical tests to understand the correlation. A p-value of <0.05 is considered statistically significant correlation of the variables analysed. | 5th August 2020 | |
Secondary | Correlation of the nearest Dental treatment seeking time and Fear of COVID-19 infection. | The survey data is statistically analyzed to check for the correlation of the nearest Dental treatment seeking time and Fear of COVID-19 infection. The data obtained from the survey is subjected to appropriate analytical statistical tests to understand the correlation. A p-value of <0.05 is considered statistically significant correlation of the variables analysed. | 5th August 2020 | |
Secondary | Correlation of the nearest Dental treatment seeking time and Dental Anxiety | The survey data is statistically analyzed to check for the correlation of the nearest Dental treatment seeking time and Dental Anxiety. The data obtained from the survey is subjected to appropriate analytical statistical tests to understand the correlation. A p-value of <0.05 is considered statistically significant correlation of the variables analysed. | 5th August 2020 | |
Secondary | Correlation of the Age and Fear of COVID-19 infection | The survey data is statistically analyzed to check for the correlation of Age and Fear of COVID-19 infection The data obtained from the survey is subjected to appropriate analytical statistical tests to understand the correlation. A p-value of <0.05 will be considered statistically significant correlation of the variables analysed. | 5th August 2020 | |
Secondary | Correlation of the Age and Dental Anxiety. | The survey data is statistically analyzed to check for the correlation of the Age and Dental Anxiety. The data obtained from the survey is subjected to appropriate analytical statistical tests to understand the correlation. A p-value of <0.05 is considered statistically significant correlation of the variables analysed. | 5th August 2020 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |